TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+1.3%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.45B
AUM Growth
-$11.8M
(-0.48%)
Cap. Flow
-$7.06M
Cap. Flow
% of AUM
-0.29%
Top 10 Holdings %
Top 10 Hldgs %
40.31%
Holding
207
New
13
Increased
45
Reduced
58
Closed
10
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$8.44M |
| 2 |
Intuitive Surgical
ISRG
|
$8.07M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$7.96M |
| 4 |
Boston Scientific
BSX
|
$6.82M |
| 5 |
Gilead Sciences
GILD
|
$5.86M |
Top Sells
| 1 |
Biogen
BIIB
|
$21M |
| 2 |
Illumina
ILMN
|
$14.4M |
| 3 |
Elevance Health
ELV
|
$10.7M |
| 4 |
AGN
Allergan plc
AGN
|
$8.2M |
| 5 |
Welltower
WELL
|
$6.93M |
Sector Composition
| 1 | Healthcare | 95.11% |
| 2 | Real Estate | 2.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
51
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $11.8M | 0.48% |
94,889
| – | – |
|
52
Alnylam Pharmaceuticals
ALNY
$59.2B
| $11.7M | 0.48% |
161,372
+27,914
| +21% | +$2.03M |
|
|
GWPH
53
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $11.1M | 0.45% |
64,499
+29,608
| +85% | +$5.1M |
|
54
FibroGen
FGEN
$48.9M
| $11M | 0.45% |
9,773
+2,743
| +39% | +$3.1M |
|
|
AMRN
55
Amarin Corp
AMRN
$317M
| $10.7M | 0.44% |
27,665
-2,903
| -9% | -$1.13M |
|
|
MDCO
56
DELISTED
Medicines Co
MDCO
| $10.1M | 0.41% |
278,092
-15,300
| -5% | -$558K |
|
57
Nektar Therapeutics
NKTR
$764M
| $10.1M | 0.41% |
18,912
| – | – |
|
58
Omega Healthcare
OHI
$12.7B
| $10M | 0.41% |
272,766
-67,500
| -20% | -$2.48M |
|
59
Jazz Pharmaceuticals
JAZZ
$7.86B
| $9.62M | 0.39% |
67,471
| – | – |
|
60
Zimmer Biomet
ZBH
$20.9B
| $9.38M | 0.38% |
82,044
| – | – |
|
61
Sabra Healthcare REIT
SBRA
$4.56B
| $9.18M | 0.37% |
466,247
| – | – |
|
|
BPMC
62
DELISTED
Blueprint Medicines
BPMC
| $8.96M | 0.37% |
94,976
-20,744
| -18% | -$1.96M |
|
63
GSK
GSK
$81.6B
| $8.75M | 0.36% |
174,960
| – | – |
|
64
Esperion Therapeutics
ESPR
$540M
| $8.59M | 0.35% |
184,607
| – | – |
|
|
ABMD
65
DELISTED
Abiomed Inc
ABMD
| $8.52M | 0.35% |
32,716
+8,730
| +36% | +$2.27M |
|
66
Ascendis Pharma
ASND
$12.5B
| $8.48M | 0.35% |
73,647
+12,287
| +20% | +$1.41M |
|
67
CRISPR Therapeutics
CRSP
$4.99B
| $8.4M | 0.34% |
178,348
| – | – |
|
68
Ionis Pharmaceuticals
IONS
$9.76B
| $8.2M | 0.33% |
127,598
+17,878
| +16% | +$1.15M |
|
69
SPDR S&P Biotech ETF
XBI
$5.39B
| $7.81M | 0.32% |
89,022
| – | – |
|
70
Align Technology
ALGN
$10.1B
| $7.74M | 0.32% |
28,278
| – | – |
|
|
XLRN
71
DELISTED
Acceleron Pharma Inc.
XLRN
| $7.74M | 0.32% |
188,388
| – | – |
|
72
Dentsply Sirona
XRAY
$2.92B
| $7.41M | 0.3% |
126,921
-29,600
| -19% | -$1.73M |
|
73
Sutro Biopharma
STRO
$89.9M
| $7.3M | 0.3% |
641,268
| – | – |
|
74
Teva Pharmaceuticals
TEVA
$21.7B
| $7.25M | 0.3% |
785,851
-105,138
| -12% | -$970K |
|
75
Agios Pharmaceuticals
AGIO
$2.09B
| $7.25M | 0.3% |
145,342
+53,566
| +58% | +$2.67M |
|